Skip to main content

Neuropsychological outcome of zidovudine (AZT, Retrovir) treatment of patients with AIDS and AIDS-related complex: Results of a double-blind, placebo-controlled trial

Publication ,  Journal Article
Schmitt, FA; Bigley, JW; McKinnis, R; Logue, PE; Evans, RW; Drucker, JL; Collaborative Working Group, AZT
Published in: New England Journal Medicine
1988

Duke Scholars

Published In

New England Journal Medicine

Publication Date

1988

Volume

319

Issue

14

Start / End Page

1573 / 1578
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Schmitt, F. A., Bigley, J. W., McKinnis, R., Logue, P. E., Evans, R. W., Drucker, J. L., & Collaborative Working Group, A. Z. T. (1988). Neuropsychological outcome of zidovudine (AZT, Retrovir) treatment of patients with AIDS and AIDS-related complex: Results of a double-blind, placebo-controlled trial. New England Journal Medicine, 319(14), 1573–1578.
Schmitt, F. A., J. W. Bigley, R. McKinnis, P. E. Logue, R. W. Evans, J. L. Drucker, and A. Z. T. Collaborative Working Group. “Neuropsychological outcome of zidovudine (AZT, Retrovir) treatment of patients with AIDS and AIDS-related complex: Results of a double-blind, placebo-controlled trial.” New England Journal Medicine 319, no. 14 (1988): 1573–78.
Schmitt FA, Bigley JW, McKinnis R, Logue PE, Evans RW, Drucker JL, et al. Neuropsychological outcome of zidovudine (AZT, Retrovir) treatment of patients with AIDS and AIDS-related complex: Results of a double-blind, placebo-controlled trial. New England Journal Medicine. 1988;319(14):1573–8.
Schmitt FA, Bigley JW, McKinnis R, Logue PE, Evans RW, Drucker JL, Collaborative Working Group AZT. Neuropsychological outcome of zidovudine (AZT, Retrovir) treatment of patients with AIDS and AIDS-related complex: Results of a double-blind, placebo-controlled trial. New England Journal Medicine. 1988;319(14):1573–1578.

Published In

New England Journal Medicine

Publication Date

1988

Volume

319

Issue

14

Start / End Page

1573 / 1578